BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
LeadActivity from announced rounds
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
Builds highly maneuverable orbital transfer vehicles and kick stages for in-space mobility and satellite logistics
Builds purpose-built hardware and software to make AI inference cheaper and energy-efficient
Builds counter-drone and missile interceptor defense systems
Develops autonomous platforms for maritime superiority
Runs autonomous AI agents that continuously probe software for vulnerabilities at machine speed
Uses interpretability to understand, learn from, and design AI systems
Builds purpose-built hardware and software to make AI inference cheaper and energy-efficient
Develops automated cell therapy manufacturing platforms